tirzepatide scholarly articles on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial The promise of tirzepatide: A

Frontiers in Endocrinology Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide Thomas R Pieber et al.

Children 12 and older show a 4% rate of hair loss with Wegovy

If javascript is disabled in your browser, some functionality may be impaired

Donna Newman made me feel heard and confident in my treatment plan

A safety and outcomes survey of long-term intranasal users found that almost half of those with allergies or sinusitis reported fewer sinus infections after starting therapy

Stephen Powis, the National Health Service (NHS) England medical director, also warned people against using such drugs as a "quick fix" to get "beach body ready." "We know these new drugs will be a powerful part of our arsenal dealing with obesity, but they should not be abused